Education
About Us
Working with TipRanks
Follow Us
AlzeCure Pharma AB (SE:ALZCUR)
:ALZCUR
Total Valuation
AlzeCure Pharma AB has a market cap or net worth of kr218.91M. The enterprise value is kr178.29M.
Market Capkr218.91M
Enterprise Valuekr178.29M
Share Statistics
AlzeCure Pharma AB has 114,914,450 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding114,914,450
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
AlzeCure Pharma AB’s return on equity (ROE) is -1.45 and return on invested capital (ROIC) is -139.15%.
Return on Equity (ROE)-1.45
Return on Assets (ROA)-0.81
Return on Invested Capital (ROIC)-139.15%
Return on Capital Employed (ROCE)-1.39
Revenue Per Employee0.00
Profits Per Employee-4.33M
Employee Count11
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of AlzeCure Pharma AB is ―. AlzeCure Pharma AB’s PEG ratio is -1.94.
PE Ratio―
PS Ratio0.00
PB Ratio6.11
Price to Fair Value6.11
Price to FCF-5.81
Price to Operating Cash Flow-6.46
PEG Ratio-1.94
Income Statement
In the last 12 months, AlzeCure Pharma AB had revenue of 0.00 and earned -47.65M in profits. Earnings per share was -0.47.
Revenue0.00
Gross Profit-1.27M
Operating Income-49.37M
Pretax Income-47.67M
Net Income-47.65M
EBITDA-48.10M
Earnings Per Share (EPS)-0.47
Cash Flow
In the last 12 months, operating cash flow was -25.87M and capital expenditures -124.00K, giving a free cash flow of -26.00M billion.
Operating Cash Flow-25.87M
Free Cash Flow-26.00M
Free Cash Flow per Share-0.23
Dividends & Yields
AlzeCure Pharma AB pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.06
52-Week Price Change-13.17%
50-Day Moving Average1.96
200-Day Moving Average2.59
Relative Strength Index (RSI)46.45
Average Volume (3m)52.87K
Important Dates
AlzeCure Pharma AB upcoming earnings date is May 5, 2026, TBA (Confirmed).
Last Earnings DateFeb 26, 2026
Next Earnings DateMay 5, 2026
Ex-Dividend Date―
Financial Position
AlzeCure Pharma AB as a current ratio of 2.33, with Debt / Equity ratio of 15.55%
Current Ratio2.33
Quick Ratio2.33
Debt to Market Cap0.01
Net Debt to EBITDA0.94
Interest Coverage Ratio-180.85
Taxes
In the past 12 months, AlzeCure Pharma AB has paid 18.00K in taxes.
Income Tax18.00K
Effective Tax Rate>-0.01
Enterprise Valuation
AlzeCure Pharma AB EV to EBITDA ratio is -3.24, with an EV/FCF ratio of -4.50.
EV to Sales0.00
EV to EBITDA-3.24
EV to Free Cash Flow-4.50
EV to Operating Cash Flow-4.50
Balance Sheet
AlzeCure Pharma AB has kr59.19M in cash and marketable securities with kr2.83M in debt, giving a net cash position of kr56.35M billion.
Cash & Marketable Securitieskr59.19M
Total Debtkr2.83M
Net Cashkr56.35M
Net Cash Per Sharekr0.49
Tangible Book Value Per Sharekr0.33
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for AlzeCure Pharma AB is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast15.74%